S.Korea’s CDMO giant Samsung Biologics to offer CRO services

Samsung Biologics Co., the world’s largest contract drugmaker, will enter the contract research organization (CRO) market by leveraging its va...
Samsung Biologics Co., the world’s largest contract drugmaker, will enter the contract research organization (CRO) market by leveraging its va...
C&R Research Inc., South Korea’s top contract research organization (CRO), plans to establish units in the US and Thailand this year while...
South Korean artificial intelligence (AI) drugmaker Syntekabio Inc. has partnered up with a US clinical research organization (CRO) to enter the wor...
Korea Investment Corporation (KIC) said on Wednesday it has promoted Lee Hoon, its former head of investment strategy and innovation division, to th...